Martini, A., Jia, R., Ferket, B. S., Waingankar, N., Plimack, E. R., Crabb, S. J., Harshman, L. C., Yu, E. Y., Powles, T., Rosenberg, J. E., Pal, S. K., Vaishampayan, U. N., Necchi, A., Wiklund, N. P., Mehrazin, R., Mazumdar, M., Sfakianos, J. P., & Galsky, M. D. (2019). tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle‐invasive bladder cancer. Cancer, 125(18), 3155–3163. http://access.bl.uk/ark:/81055/vdc_100090706990.0x00005b